Related Experiment Video
Updated: Jul 11, 2025
04:59
Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
12.2K
A rare case report: chronic generalized idiopathic pruritus
Iya Agha1, Emmanuel Khodra1, Ryan Cornell1
1New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, USA.
AME Case Reports
|November 9, 2023
Summary
Gabapentin effectively controlled chronic idiopathic pruritus in a patient unresponsive to other treatments. This finding suggests gabapentinoids may be a valuable option for managing generalized chronic pruritus (CP) and improving patient quality of life.
Area of Science:
- Dermatology
- Neurology
- Pharmacology
Background:
- Generalized chronic pruritus (CP) presents diagnostic and therapeutic challenges, often lacking a clear underlying cause.
- Idiopathic pruritus significantly diminishes patients' quality of life.
- Standard treatments like antihistamines and steroids are not always effective for CP.
Observation:
- A 56-year-old male presented with intense, diffuse pruritus over seven weeks.
- Previous treatments for his idiopathic generalized pruritus were unsuccessful.
- The patient experienced significant symptom relief with gabapentin.
Findings:
- Gabapentin, an antiepileptic and neuropathic pain medication, demonstrated efficacy in treating refractory chronic pruritus.
- This case highlights the potential of gabapentinoids as an understudied treatment for generalized chronic pruritus (CP).
Implications:
- Gabapentin may offer a new therapeutic avenue for patients with uncontrolled idiopathic generalized pruritus.
- Further research into gabapentinoids for CP is warranted to establish their role in treatment guidelines.
- Successful management of CP with gabapentin can significantly improve patients' quality of life.
